XBI icon

SPDR S&P Biotech ETF

743 hedge funds and large institutions have $8.2B invested in SPDR S&P Biotech ETF in 2022 Q4 according to their latest regulatory filings, with 122 funds opening new positions, 231 increasing their positions, 240 reducing their positions, and 63 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding

Funds holding:

0.1% more ownership

Funds ownership: 94.67%94.78% (+0.1%)

4% less repeat investments, than reductions

Existing positions increased: 231 | Existing positions reduced: 240

6% less funds holding in top 10

Funds holding in top 10: 3331 (-2)

Holders
743
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
31
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.66B
Puts
$1.31B
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
301
$1.12M
302
$1.12M
303
$1.12M
304
$1.11M
305
$1.11M
306
$1.11M
307
$1.1M
308
$1.09M
309
$1.08M
310
$1.07M
311
$1.07M
312
$1.07M
313
$1.06M
314
$1.06M
315
$1.05M
316
$1.05M
317
$1.04M
318
$1.03M
319
$1.03M
320
$1.01M
321
$1.01M
322
$1M
323
$990K
324
$976K
325
$971K